Back to Search
L GLODE, MD
MD
Medical Oncology Physician
NPI: 1730279415Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
21712(CO)
Research & Publications (18)
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma.
PMID 14534880·Cancer·2003
8-other
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
PMID 18089718·Mol Cancer Ther·2007
7-preclinical
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.
PMID 17538166·J Clin Oncol·2007
3-trial
Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
PMID 15613448·Endocr Relat Cancer·2004
6-review
A comprehensive characterization of the peptide and protein constituents of human seminal fluid.
PMID 15305340·Prostate·2004
8-other
The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial.
PMID 15264245·Prostate·2004
3-trial
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
PMID 15117815·Carcinogenesis·2004
8-other
Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor.
PMID 15026348·Cancer Res·2004
7-preclinical
Prostate cancer on the internet: impact on patients and how technology helps physicians and researchers.
PMID 15040881·Clin Prostate Cancer·2003
8-other
Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
PMID 14651997·Biochem Biophys Res Commun·2003
4-observational
GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines.
PMID 13680022·Urol Res·2003
7-preclinical
Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
PMID 12866029·Int J Cancer·2003
8-other
High Gleason scores and lower prostate-specific antigen levels in a single institution over the past decade.
PMID 15046702·Clin Prostate Cancer·2002
4-observational
Internet oncology: increased benefit and risk for patients and oncologists.
PMID 11525299·Hematol Oncol Clin North Am·2001
6-review
Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo.
PMID 10677563·Int J Mol Med·2000
8-other
Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
PMID 10970725·Mol Cell Probes·2000
4-observational
A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.
PMID 10890744·Hum Gene Ther·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1730279415
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile